The UAB Institutional Review Board has approved another blinded, randomized controlled trial with high functioning ASD students, ages 3-6, using the current version of FaceSay as the intervention. Enrollment is expected to reach over 30. |
The UAB Institutional Review Board has approved another blinded, randomized controlled trial with high functioning ASD students, ages 3-6, using the current version of FaceSay as the intervention. Enrollment is expected to reach over 30. |
Copyright © 2007-2008, Symbionica, LLC, All Rights Reserved